Simple jQuery Dropdowns

Browsing by Author David A. Cooper

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
1-Sep-2011Accelerating the development of an AIDS vaccine: The AIDS vaccine for Asia network (AVAN)Punnee Pitisuttithum; Supachai Rerks-Ngarm; Joseph Chiu; Jerome Kim; Michael Benenson; Stephen J. Kent; Hiko Tamashiro; Amapola Manrique; Alan Bernstein; Rajat Goyal; Rossana A. Ditangco; David A. Cooper; Saladin Osmanov; Bonnie Mathieson; Eric Sandstrom; Jose Esparza; Rodney Hoff; Yiming Shao; Mahidol University; Thailand Ministry of Public Health; Armed Forces Research Institute of Medical Sciences, Thailand; US Military HIV Research Program; University of Melbourne; Hokkaido University; Global HIV Vaccine Enterprise; International AIDS Vaccine Initiative (IAVI); Gokila; University of New South Wales (UNSW) Australia; Organisation Mondiale de la Sante; National Institutes of Health, Bethesda; Karolinska University Hospital; Bill and Melinda Gates Foundation; Regional Emerging Diseases Intervention Centre; National Center for AIDS/STD Control and Prevention
1-Sep-2010AIDS Vaccine for Asia Network (AVAN): Expanding the regional role in developing HIV vaccinesStephen J. Kent; David A. Cooper; Mean Chhi Vun; Yiming Shao; Linqi Zhang; Nirmal Ganguly; Budiman Bela; Hiko Tamashiro; Rossana Ditangco; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Nguyen van Kinh; Alan Bernstein; Saladin Osmanov; University of Melbourne; University of New South Wales (UNSW) Australia; National Center for HIV/AIDS; National Center for AIDS/STD Control and Prevention; Tsinghua University; Indian Council of Medical Research; Universitas Indonesia; Hokkaido University; Gokila; Thailand Ministry of Public Health; Mahidol University; National Institute for Infectious and Tropical Diseases; Global HIV Vaccine Enterprise; Organisation Mondiale de la Sante
1-Sep-2010Defining the objectives of the AIDS vaccine for Asia network: Report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in AsiaSupachai Rerks-Ngarm; Punnee Pitisuttithum; Nirmal Ganguly; Linqi Zhang; Hiko Tamashiro; David A. Cooper; Mean Chhi Vun; Budiman Bela; Rossana Ditangco; Nguyen Van Kinh; Alan Bernstein; Saladin Osmanov; Bonnie Mathieson; Stephen J. Kent; Yiming Shao; Thailand Ministry of Public Health; Mahidol University; Indian Council of Medical Research; Tsinghua University; Hokkaido University; University of New South Wales (UNSW) Australia; National Center for HIV/AIDS; Universitas Indonesia; Gokila; National Institute for Infectious and Tropical Diseases; Global HIV Vaccine Enterprise; Organisation Mondiale de la Sante; National Institutes of Health, Bethesda; University of Melbourne; National Center for AIDS
1-Aug-2016Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trialTorsak Bunupuradah; Sasisopin Kiertiburanakul; Anchalee Avihingsanon; Ploenchan Chetchotisakd; Malee Techapornroong; Niramon Leerattanapetch; Pacharee Kantipong; Chureeratana Bowonwatanuwong; Sukit Banchongkit; Virat Klinbuayaem; Sripetcharat Mekviwattanawong; Sireethorn Nimitvilai; Supunnee Jirajariyavej; Wisit Prasithsirikul; Warangkana Munsakul; Sorakij Bhakeecheep; Suchada Chaivooth; Praphan Phanuphak; David A. Cooper; Tanakorn Apornpong; Stephen J. Kerr; Sean Emery; Kiat Ruxrungtham; The HIV Netherlands Australia Thailand Research Collaboration; Mahidol University; Khon Kaen University; Prapokklao Hospital; Khon Kaen Regional Hospital; Chiangrai Prachanukroh Hospital; Chonburi Regional Hospital; Rayong Hospital; Sanpatong Hospital; Pranangklao Hospital; Nakhon Phatom Hospital; Taksin Hospital; Bamrasnaradura Infectious Disease Institute; Bangkok Metropolitan Administration; National Health Security Office; University of New South Wales (UNSW) Australia; Academic Medical Centre, University of Amsterdam; Chulalongkorn University
1-Dec-2005Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosisReshma S. Autar; Ferdinand W.N.M. Wit; Jongkol Sankote; Apicha Mahanontharit; Thanomsak Anekthananon; Piroon Mootsikapun; Khanjtta Sujaikaew; David A. Cooper; Joep M.A. Lange; Praphan Phanuphak; Kiat Ruxrungtham; David M. Burger; The HIV Netherlands Australia Thailand Research Collaboration; University of Amsterdam; Mahidol University; Khon Kaen University; Kirby Institute; University of New South Wales (UNSW) Australia; PharmAccess Foundation; Chulalongkorn University; Radboud University Nijmegen Medical Centre
6-Oct-2005A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patientsJintanat Ananworanich; Andrew Hill; Umaporn Siangphoe; Kiat Ruxrungtham; Wisit Prasithsirikul; Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Warangkana Munsakul; Phitsanu Raksakulkarn; Somboon Tansuphasawadikul; Reto Nuesch; David A. Cooper; Bernard Hirschel; The HIV Netherlands Australia Thailand Research Collaboration; University of Liverpool; Chulalongkorn University; Bamrasnaradura Infectious Disease Institute; Khon Kaen University; Mahidol University; Vajira Hospital; San Pa Tong Hospital; Buddhachinnaraj Hospital; Universitatsspital Basel; Kirby Institute; Hopitaux universitaires de Geneve
1-Jun-2001A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patientsChaiwat Ungsedhapand; Eugene D.M.B. Kroon; Surapol Suwanagool; Kiat Ruxrungtham; Nongluk Yimsuan; Areerat Sonjai; Sasiwimol Ubolyam; Supranee Buranapraditkun; Surapee Tiengrim; Nadine Pakker; Chaiyos Kunanusont; Joep M.A. Lange; David A. Cooper; Praphan Phanuphak; The HIV Netherlands Australia Thailand Research Collaboration; Academic Medical Centre, University of Amsterdam; Mahidol University; Chulalongkorn University; Thailand Ministry of Public Health; Kirby Institute
1-Jun-2004Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infectionChaiwat Ungsedhapand; Preeyaporn Srasuebkul; Peter Cardiello; Kiat Ruxrungtham; Winai Ratanasuwan; Eugene D M B Kroon; Metta Tongtalung; Nittaya Juengprasert; Sasiwimol Ubolyam; Umaporn Siangphoe; Sean Emery; Joep M A Lange; David A. Cooper; Praphan Phanuphak; Thai Red Cross Agency; Academic Medical Centre, University of Amsterdam; Chulalongkorn University; Mahidol University; Kirby Institute